Jamieson, A;
Finer, N;
(2017)
Can we reconcile ‘the obesity paradox’ with recent cardiovascular outcome trials in diabetes?
Clinical Obesity
, 7
(5)
pp. 255-259.
10.1111/cob.12217.
Preview |
Text
Finer_Can we reconcile the obesity paradox with recent cardiovascular outcome trials in diabetes_AAM.pdf - Accepted Version Download (737kB) | Preview |
Abstract
Several recent cardiovascular outcome trials (CVOT) in patients with type 2 diabetes have shown benefit in terms of both weight loss and cardiovascular benefit. At the same time a number of epidemiological studies have shown that a body mass index above 25 kg/m² may be beneficial - the so-called ‘obesity paradox’. We discuss whether these CVOT support the potential benefits of intentional or therapeutic weight loss, but conclude that such conclusions would be simplistic and will require trials specifically designed for this purpose.
| Type: | Article |
|---|---|
| Title: | Can we reconcile ‘the obesity paradox’ with recent cardiovascular outcome trials in diabetes? |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/cob.12217 |
| Publisher version: | https://doi.org/10.1111/cob.12217 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10058243 |
Archive Staff Only
 |
View Item |
